Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...

Shares of Regeneron Pharmaceuticals Inc. slipped 3.03% to $545.94 Monday, on what proved to be an all-around poor trading ...

Our Health Care Litigation Team discusses a District of Massachusetts case holding that allows the government to switch liability theories in ...

Regeneron Court Permits Government to Pursue False Certification Theory - On August 4, the district court in the closely ...

Dr. Reid brings 30 years of experience in building biotech companies based on innovative scientific platforms and shaping ...

Plus more pharma news from the Pharmalittle newsletter.

Truist on Monday lowered its price target on Regeneron (REGN) to $812 from $940, citing concerns with the company’s Eylea ...

Adam Kovalčík, a 19-year-old from Slovakia, secured a top prize at an international science competition. He developed a ...

Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP ...

Cash, cash equivalents, marketable securities and restricted cash as of June 30, 2025, totaled approximately $408.2 million VYGLXIA NDA for spinocerebellar ataxia ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...